F
FIBROBIOLOGICS, INC. COMMON STOCK
NASDAQ: FBLG (FibroBiologics, Inc.)
Kemas kini terakhir: semalam, 8:20PM0.980
0.02 (2.06%)
| Penutupan Terdahulu | 0.960 |
| Jumlah Dagangan | 41,010 |
| Harga / Buku (P/B) | 1.27 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -0.210 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 302.81% |
| Nisbah Semasa (MRQ) | 1.14 |
| Aliran Tunai Operasi (OCF TTM) | -12.90 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -17.74 M |
| Pulangan Atas Aset (ROA TTM) | -81.15% |
| Pulangan Atas Ekuiti (ROE TTM) | -559.73% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | FibroBiologics, Inc. | Bercampur | Menurun |
AISkor Stockmoo
| Nilai 35% | -4.4 |
| AI Insight info | NA |
| Penilaian Relatif info | NA |
| Kesihatan Kewangan info | -4.4 |
| Masa 35% | -0.5 |
| AI Technical info | NA |
| Osilator Teknikal info | -2.5 |
| Purata Bergerak Teknikal info | 2.5 |
| Wang Pintar 30% | 0.0 |
| Konsensus Penganalisis info | 0.0 |
| Aktiviti Orang Dalam info | NA |
| Persekitaran | ×1.21 |
| Persekitaran Makro info | -3.3 |
| Sektor berbanding Pasaran (6B) | -21.3% |
| Persetujuan Tonggak | ×1.25 |
| Tidak dikira dalam skor | |
| Volatiliti Harga info | 0.1 |
| Skor Akhir | -2.60 |
|
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 21.42% |
| % Dimiliki oleh Institusi | 16.75% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Cascade Financial Partners, Llc | 30 Jun 2026 | 108,828 |
| Ifp Advisors, Inc | 30 Sep 2026 | 27,000 |
| Grove Bank & Trust | 30 Sep 2026 | 100 |
Tiada data dalam julat masa ini.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |